Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect
Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure | BMC Nephrology | Full Text
N Latex FLC kappa & lambda Assays - Siemens Healthineers
Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease | Scientific Reports
J Clin Med Res
Light Chain Deposition Disease | UNC Kidney Center
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
Frontiers | Can urine studies be replaced by serum free light chains measurements to assign responses in multiple myeloma patients?
JCM | Free Full-Text | The Role of Light Kappa and Lambda Chains in Heart Function Assessment in Patients with AL Amyloidosis
Serum free light chain ratio predicts outcome in MGUS | Semantic Scholar
Distribution of SFLCA Results of Patients With Monoclonal Gammopathies... | Download Table
Correspondence data for kappa and lambda free light chain analysis | Download Table
Following & Understanding Your Free Light Chain Test Results - YouTube
Serum Free Light Chains Blood Test
Cureus | Light-Chain Multiple Myeloma: A Diagnostic Challenge | Article
Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease | PLOS ONE
Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma | Blood Cancer Journal
PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Phenotyping Polyclonal Kappa and Lambda Light Chain Molecular Mass Distributions in Patient Serum Using Mass Spectrometry | Journal of Proteome Research